1 / 4

Global Cardiac Biomarkers Market 2014-2018 Report

This report covers the present scenario and growth prospects of the Global Cardiac Biomarkers market, including the different types of assays used for cardiac biomarkers. The market is expected to grow at a CAGR of 12.75% between 2013-2018.

parkhill
Download Presentation

Global Cardiac Biomarkers Market 2014-2018 Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Cardiac Biomarkers Market 2014-2018

  2. Report Description About Cardiac Biomarker A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, and sCD40L. Cardiac biomarker assays help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in the diagnosis and treatment of CVDs. The abnormal concentration of these biomarkers will act as significant predictors of an adverse cardiovascular condition. Cardiac point of care (POC) testing offers reliable measurement of cardiac biomarkers and provides results within one hour of testing. In addition to saving time, some cardiac POC tests have been modified to improve the accuracy of the measurement of enzymes to reduce operational error. Get complete Report @ http://www.bigmarketresearch.com/global-cardiac-biomarkers-2014-2018-market Global Cardiac Biomarkers market to grow at a CAGR of 12.75 percent over the period 2013-2018.

  3. Report Description Covered in this Report This report covers the present scenario and the growth prospects of the Global Cardiac Biomarkers market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of devices and assays used for cardiac biomarkers to diagnose various cardiovascular diseases. The market is segmented based on the following type of assay: • Troponin (cTnI and cTnT) • BNP & NT-proBNP • CK-MB • Myogloblin • Others (hs-CRP, D-Dimer, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, AST, FFAu, and sCD40L) Get Enquired about this report @ http://www.bigmarketresearch.com/report-enquiry/150077

  4. Interesting, right? This is just a sneak preview of the full presentation. We hope you like it! To see the rest of it, just click here to view it in full on PowerShow.com. Then, if you’d like, you can also log in to PowerShow.com to download the entire presentation for free.

More Related